Last reviewed · How we verify
NCT04694261: SM-ART
Development and Evaluation of SM-ART Intervention (SM-ART)
NA trial testing SM-ART in Perinatal Depression in 200 participants. Completed in 31 December 2021.
30 June 2021
Quick facts
| Lead sponsor | Aga Khan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 1 July 2019 |
| Primary completion | 30 June 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- SM-ART
Conditions studied
- Perinatal Depression — all drugs for Perinatal Depression →
- Resilience — all drugs for Resilience →
- Anxiety — all drugs for Anxiety →
- Marital Conflict — all drugs for Marital Conflict →
Sponsor
Aga Khan University
Who can join
18 and older, female only, with Perinatal Depression or Resilience. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The approach of this intended research is to help pregnant women practice constructive coping and proactive skills that focus on positive adaptation for safe motherhood through our developed intervention. The objective of this two phases Randomized Control Trial is to develop contextually based "SM-ART" intervention \[Safe Motherhood ART: Accessible Resilience Training\] and evaluate the effectiveness of "SM-ART" intervention in a sample of pregnant women living in low socioeconomic urban areas of Karachi, Pakistan. It is hypothesized that the SM-ART intervention will enhance resilience and marital harmony and decrease symptoms of depression, anxiety in pregnant women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Promoting mental wellbeing in pregnant women living in Pakistan with the Safe Motherhood-Accessible Resilience Training (SM-ART) intervention: a randomized controlled trial.
Bhamani SS, Van Parys AS, Arthur D, Letourneau N, et al · · 2024 · cited 1× · PMID 38951777 · DOI 10.1186/s12884-024-06629-2
Verify or expand the search:
- PubMed search for NCT04694261
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Perinatal Depression
Currently open trials in the same condition.
- NCT06790641 — Pathways to Perinatal Mental Health Equity · NA · recruiting
- NCT06968390 — Accelerated TMS for Perinatal Depression · NA · recruiting
- NCT06594263 — Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA) · recruiting
- NCT06364488 — TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety · NA · recruiting
- NCT06473935 — Maternal Well-being in the Perinatal Period · recruiting
Other Aga Khan University trials
Trials by the same sponsor.
- NCT07475793 — Image Guided Genicular Nerve Radiofrequency Ablation for Chronic Knee Osteoarthritis · NA · not yet recruiting
- NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
- NCT07356063 — Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA · NA · not yet recruiting
- NCT07451951 — Effectiveness of SQLNS vs MQLNS for Prevention of Undernutrition in Children 6-12 Months · NA · not yet recruiting
- NCT07357350 — Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04694261 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aga Khan University
- Last refreshed: 3 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04694261.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing